Clinical Trials Browser

Pancreatic Intraductal Neoplasms × tocotrienol, delta × Gastrointestinal × Clear all

NCT06519097 2025-11-13

Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT00985777 2016-03-01

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Phase 1 Completed

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms